银屑病关节炎放射学骶髂关节炎进展
该前瞻性队列研究分析了1978至2025年1554例银屑病关节炎患者,发现45%的患者骶髂关节炎评分至少进展1级;炎症活动度高与进展风险增加相关,而生物制剂/靶向合成DMARD暴露和较晚治疗时代与进展率降低相关。
要点
- 银屑病关节炎患者放射学骶髂关节炎进展常见,45%评分至少增加1级。
- 男性、关节肿胀数、PASI、甲病、ESR/CRP异常、DAPSA高与进展相关。
- 生物制剂/靶向合成DMARD暴露及较晚治疗时代与进展率降低相关。
核心结论
- 银屑病关节炎放射学骶髂关节炎进展常见,炎症活动度高增加风险,生物制剂/靶向合成DMARD暴露具保护作用,现代治疗时代进展率更低。
研究设计与样本
- 前瞻性银屑病关节炎队列(1978-2025年),每半年拍摄骨盆X线,排除基线骶髂关节炎评分8分者,共1554例符合条件患者,中位随访6.00年。
主要发现
- 475/1056(45%)患者骶髂关节炎评分至少进展1级。
- 单变量分析中男性、66关节肿胀数、PASI、甲病、韧带骨赘、ESR/CRP异常及较高DAPSA与进展相关,年龄较大和病程较长与进展较少相关。
- 多变量模型中年龄较大和生物制剂/靶向合成DMARD暴露保持保护性关联。
- 831例基线无明确改良纽约标准骶髂关节炎且至少1次随访X线者中,189例(22.7%)发展为明确改良纽约标准骶髂关节炎。
关键数值与推荐
- 骶髂关节炎总和评分(SSS,0-8分,左右侧改良纽约分级之和)变化为主要结局。
- 采用线性混合效应模型评估SSS变化相关因素,Cox回归评估新发改良纽约标准骶髂关节炎时间。
临床怎么用
- 对银屑病关节炎患者应关注炎症活动度(ESR/CRP、DAPSA、PASI等)以评估骶髂关节炎进展风险。
- 生物制剂/靶向合成DMARD暴露与放射学进展率降低相关,支持积极控制炎症的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess radiographic sacroiliitis progression in PsA and factors associated with it. METHODS: We analysed a prospective PsA cohort (1978-2025). Pelvic radiographs were obtained biannually. Change (Δ) in the sacroiliitis sum score (SSS, 0-8; left + right modified New York-mNY-grades) was the primary outcome, while patients with SSS = 8 at baseline were excluded from the analyses. Linear mixed-effects models assessed factors associated with ΔSSS over successive clinic visits. As a secondary outcome, time to incident mNY sacroiliitis was evaluated with Cox regression. RESULTS: Among 1554 eligible patients (median follow-up 6.00 years), 475/1056 (45%) showed progression in SSS by at least one grade. In univariable analyses, male sex, 66-joint swollen count, PASI, nail disease, syndesmophytes, abnormal ESR/CRP and higher DAPSA were associated with progression, while older age and longer PsA duration were associated with less progression. Biologic/targeted synthetic (b/ts) DMARD exposure and follow-up in the post-2011 era were associated with lower progression rates. In multivariable models, older age and b/tsDMARD exposure retained protective associations. Among 831 patients without definite mNY sacroiliitis at baseline and with ≥1 follow-up radiograph, 189 (22.7%) developed definite mNY sacroiliitis. In univariable Cox analysis, nail disease, higher PASI, abnormal ESR/CRP, higher DAPSA and syndesmophytes were associated with progression, while b/tsDMARD exposure and later eras were associated with lower progression; effects were attenuated after adjustment. CONCLUSION: Radiographic sacroiliitis progression is common in PsA. Greater inflammatory activity increased risk, whereas b/tsDMARD exposure were protective; progression was lower in the modern treatment era.
引用
- Carrizo-Abarza V, Mehta P, Kharouf F, et al. Radiographic sacroiliitis progression in psoriatic arthritis. Rheumatology (Oxford). 2026. PMID: 42384912. doi:10.1093/rheumatology/keag336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。